ANEVASC
Timeline
26 events since 2011Board
Filings
Financial
20122014201620182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBabbreviated format · 76 days late
2025
Liquidity more than doubled current ratio 46.85 The current ratio rises from 18.91 to 46.85. Short-term debt falls from €98,131 to €41,591.
Equity above €2m equity €2.0m ▲7.8% Equity rises from €1.9m to €2.0m.
Annual accounts 2024 filed PDFabbreviated format · 29 days late
Annual accounts 2023 filed PDFabbreviated format · 155 days late
2024
Company renamed from Dr. J.Callaert - vaatheelkunde & Dr. N. Van Dam - anesthesie to ANEVASC (statutory director) and (statutory director) reappointed · “De uitoefening van de geneeskunde door de arts-vennoot,dit alles in naam en voor rekening van de…” (deed in Dutch) · General meeting of 22-12-20235 points ▸
- General meeting, 22-12-2023
- Name change, ANEVASC
- Registered office clause, Scheepswerfstraat 13, 9200 Dendermonde
- Director reappointment, (statutory director)
- Director reappointment, (statutory director)
- The deed holds 4 more points.
2023
Highest result from 2011 to 2025 net €479,469 ▲20.3% The operating result of €678,033 and the net result of €479,469 are both a record.
Liquidity more than doubled current ratio 13.81 The current ratio rises from 5.38 to 13.81. Short-term debt falls from €312,780 to €139,668.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0832982352
Annual accounts 2022 filed PDFabbreviated format · 24 days before the deadline
2022
Annual accounts 2021 filed PDFabbreviated format · 31 days before the deadline
2021
Annual accounts 2020 filed PDFabbreviated format · 12 days before the deadline
2020
Annual accounts 2019 filed PDFabbreviated format · 60 days late
2019
Annual accounts 2018 filed PDFabbreviated format · 71 days late
2018
Equity above €1m equity €1.2m ▲54.5% Equity rises from €758,362 to €1.2m.
Annual accounts 2017 filed PDFabbreviated format · 59 days late
2017
Annual accounts 2016 filed PDFabbreviated format · 137 days late
Annual accounts 2015 filed PDFabbreviated format · 165 days late
2015
Liquidity more than doubled current ratio 3.78 The current ratio rises from 1.60 to 3.78. Short-term debt falls from €248,201 to €138,053.
Equity above €500,000 equity €526,594 ▲92.8% Equity rises from €273,168 to €526,594.
Annual accounts 2014 filed PDFabbreviated format · 151 days late
2014
Equity above €200,000 equity €273,168 ▲432% Equity rises from €51,315 to €273,168.
Annual accounts 2013 filed PDFabbreviated format · 131 days late
2013
Annual accounts 2012 filed PDFabbreviated format · 31 days late
2012
Annual accounts 2011 filed PDFabbreviated format · 83 days late
2011
IncorporationFounded by and · Founding capital of €18,600, 186 shares, €6,200 paid up · (statutory manager) and (statutory manager) appointed · published on 01-02-20116 points ▸
- Founder, , mentioned twice in the deed
- Founder,
- Founding capital, €18,600, 186 shares
- Capital, €18,600, 186 shares
- Director appointment, (statutory manager)
- Director appointment, (statutory manager)
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank